Home/Filings/4/0000899243-18-018107
4//SEC Filing

GOLD DANIEL P PHD 4

Accession 0000899243-18-018107

CIK 0001262104other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 2:27 PM ET

Size

5.5 KB

Accession

0000899243-18-018107

Insider Transaction Report

Form 4
Period: 2018-06-22
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-22+380,000380,000 total
    Exercise: $4.33Exp: 2028-06-22Common Stock (380,000 underlying)
Footnotes (1)
  • [F1]One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001288233

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 2:27 PM ET
Size
5.5 KB